1. Damsa C, Kosel M, Moussally J. Current status of brain imaging in anxiety disorders. Curr Opin Psychiatry. 2008;22(1):96–110. doi: 10.1097/YCO.0b013e328319bd10 .
2. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27. doi: 10.1001/archpsyc.62.6.617 .
3. Comer JS, Blanco C, Hasin DS, Liu SM, Grant BF, Turner JB, et al. Health-related quality of life across the anxiety disorders. J Clin Psychiatry. 2011. doi: 10.4088/JCP.09m05094blu .
4. Rauch SL. Neuorimaging and the neurobiology of anxiety disorders. In: Handbook of affective sciences. Oxford: University Press; 2003. p. 963–75.
5. Whalen PJ, Johnstone T, Somerville LH, Nitschke JB, Polis S, Alexander AL, et al. A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biol Psychiatry. 2008. doi: 10.1016/j.biopsych.2007.08.019 .